Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP420447.RAMgg6yFhE0n59rFI3dcU6SDaEOEq056mq_hK59MZAIbc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP420447.RAMgg6yFhE0n59rFI3dcU6SDaEOEq056mq_hK59MZAIbc130_assertion type Assertion NP420447.RAMgg6yFhE0n59rFI3dcU6SDaEOEq056mq_hK59MZAIbc130_head.
- NP420447.RAMgg6yFhE0n59rFI3dcU6SDaEOEq056mq_hK59MZAIbc130_assertion description "[HER2 positivity by at least one of the three techniques was most common in adenocarcinomas, at 29% (42 of 143).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP420447.RAMgg6yFhE0n59rFI3dcU6SDaEOEq056mq_hK59MZAIbc130_provenance.
- NP420447.RAMgg6yFhE0n59rFI3dcU6SDaEOEq056mq_hK59MZAIbc130_assertion evidence source_evidence_literature NP420447.RAMgg6yFhE0n59rFI3dcU6SDaEOEq056mq_hK59MZAIbc130_provenance.
- NP420447.RAMgg6yFhE0n59rFI3dcU6SDaEOEq056mq_hK59MZAIbc130_assertion SIO_000772 14614004 NP420447.RAMgg6yFhE0n59rFI3dcU6SDaEOEq056mq_hK59MZAIbc130_provenance.
- NP420447.RAMgg6yFhE0n59rFI3dcU6SDaEOEq056mq_hK59MZAIbc130_assertion wasDerivedFrom befree-2016 NP420447.RAMgg6yFhE0n59rFI3dcU6SDaEOEq056mq_hK59MZAIbc130_provenance.
- NP420447.RAMgg6yFhE0n59rFI3dcU6SDaEOEq056mq_hK59MZAIbc130_assertion wasGeneratedBy ECO_0000203 NP420447.RAMgg6yFhE0n59rFI3dcU6SDaEOEq056mq_hK59MZAIbc130_provenance.